These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. [Certain complications of corticosteroid therapy]. Aleksandrova EP; Somskova TV Klin Med (Mosk); 1973 Dec; 51(12):94-7. PubMed ID: 4779028 [No Abstract] [Full Text] [Related]
23. Exogenous Cushing's syndrome and glucocorticoid withdrawal. Hopkins RL; Leinung MC Endocrinol Metab Clin North Am; 2005 Jun; 34(2):371-84, ix. PubMed ID: 15850848 [TBL] [Abstract][Full Text] [Related]
24. [Adder bite]. Halvorsen K Tidsskr Nor Laegeforen; 1969 Apr; 89(7):486-8. PubMed ID: 5794673 [No Abstract] [Full Text] [Related]
25. [Per oral glucocorticoid is infective for viper bite]. Härkönen M Duodecim; 1995; 111(18):1803-4. PubMed ID: 9340276 [No Abstract] [Full Text] [Related]
26. Cushing's syndrome from topical glucocorticoids. Teelucksingh S; Bahall M; Coomansingh D; Suite M; Bartholomew C West Indian Med J; 1993 Jun; 42(2):77-8. PubMed ID: 8367969 [TBL] [Abstract][Full Text] [Related]
28. [Iatrogenic Cushing syndrome in neurosurgical practice]. Maretsis M; Mestes E; Arseni C Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Neurol Psihiatr Neurochir; 1974; 19(5):403-10. PubMed ID: 4549647 [No Abstract] [Full Text] [Related]
29. [Complications of the withdrawal of synthetic glucocorticoids]. Hugues FC; Le Jeunne C Therapie; 1984; 39(4):395-401. PubMed ID: 6484883 [No Abstract] [Full Text] [Related]
30. An infantile Cushing syndrome due to misuse of topical steroid. Siklar Z; Bostanci I; Atli O; Dallar Y Pediatr Dermatol; 2004; 21(5):561-3. PubMed ID: 15461763 [TBL] [Abstract][Full Text] [Related]
32. Management of Vipera berus adder bite. Jones TI; Clegg W Practitioner; 1985 Nov; 229(1409):956-8. PubMed ID: 4070161 [No Abstract] [Full Text] [Related]
33. [Side effects of the long-term treatment of skin diseases with corticosteroids]. Starzycki Z; Dembińska B Przegl Dermatol; 1983; 70(4):423-8. PubMed ID: 6669715 [No Abstract] [Full Text] [Related]
34. [Complications in glucocorticoid treatment]. Kuralesin MG Med Sestra; 1981 Feb; 40(2):48-50. PubMed ID: 6907646 [No Abstract] [Full Text] [Related]
35. Cushing's syndrome and severe adrenal suppression in patients treated with ritonavir and inhaled nasal fluticasone. Chen F; Kearney T; Robinson S; Daley-Yates PT; Waldron S; Churchill DR Sex Transm Infect; 1999 Aug; 75(4):274. PubMed ID: 10615321 [No Abstract] [Full Text] [Related]
36. Treatment of adder bite. Br Med J; 1969 Aug; 3(5667):370-1. PubMed ID: 5797770 [No Abstract] [Full Text] [Related]
37. Cushing's syndrome caused by short-term topical glucocorticoid use for erythrodermic psoriasis and development of adrenal insufficiency after glucocorticoid withdrawal. Durmazlar SP; Oktay B; Eren C; Eskioglu F Eur J Dermatol; 2009; 19(2):169-70. PubMed ID: 19106046 [No Abstract] [Full Text] [Related]
38. [Adrenocortical insufficiency due to therapy with corticosteroids]. Baumann K; Müller J Ther Umsch; 1972 Sep; 29(9):535-9. PubMed ID: 4343770 [No Abstract] [Full Text] [Related]
39. Glucocorticoidlike activity of megestrol. A summary of Food and Drug Administration experience and a review of the literature. Mann M; Koller E; Murgo A; Malozowski S; Bacsanyi J; Leinung M Arch Intern Med; 1997 Aug 11-25; 157(15):1651-6. PubMed ID: 9250225 [TBL] [Abstract][Full Text] [Related]